5.00
Electrocore Inc stock is traded at $5.00, with a volume of 43,829.
It is down -4.94% in the last 24 hours and up +1.83% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$5.26
Open:
$5.27
24h Volume:
43,829
Relative Volume:
0.57
Market Cap:
$37.92M
Revenue:
$27.70M
Net Income/Loss:
$-13.25M
P/E Ratio:
-3.0864
EPS:
-1.62
Net Cash Flow:
$-7.66M
1W Performance:
-0.20%
1M Performance:
+1.83%
6M Performance:
-9.42%
1Y Performance:
-36.71%
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ECOR
Electrocore Inc
|
5.00 | 42.06M | 27.70M | -13.25M | -7.66M | -1.62 |
![]()
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
May-09-19 | Initiated | Noble Capital Markets | Outperform |
Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Can technical indicators confirm electroCore Inc.’s reversalTrade Exit Summary & Proven Capital Preservation Tips - newser.com
Is electroCore Inc. (43E0) stock a buy before new product rolloutMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
Real time pattern detection on electroCore Inc. stockJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Real time social sentiment graph for electroCore Inc.Portfolio Update Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can machine learning forecast electroCore Inc. recoveryOil Prices & Community Verified Trade Signals - newser.com
What analysts say about electroCore Inc stockMerger & Acquisition Updates & Free Unlock Rapid Growth Potential - earlytimes.in
ElectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(4) - MarketScreener
How electroCore Inc. (43E0) stock trades after rate cutsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Using AI based signals to follow electroCore Inc.Take Profit & Consistent Growth Equity Picks - newser.com
Can electroCore Inc. stock surprise with earnings upsideJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Is electroCore Inc. trending in predictive chart modelsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
electroCore (ECOR) Files to Sell 762,508 Shares of Common Stock - GuruFocus
Electrocore Finalizes Stock Sale to Settle Legal Fees - TipRanks
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
10,000 RSUs: electroCore hires Jennifer Hayes as VP HR; grant vests 1/3 annually from Oct 6, 2025 - Stock Titan
Should You Invest in Medinova Diagnostic Services Limited Before Its Next Earnings ReportPrice Action Trading & Minimal Capital Trading Tips - earlytimes.in
What drives electroCore Inc 43E0 stock priceLong-Term Investment Plans & Affordable Investment Strategies - earlytimes.in
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as - GlobeNewswire
electroCore’s Board Elects New Chairman - Medical Product Outsourcing
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms - Yahoo Finance
34% Recovery Rate: electroCore's Non-Invasive Brain Treatment Shows Promise for 2.5M Annual TBI Patients - Stock Titan
What drives electroCore Inc stock priceDividend Stock Watch & Start Your Free Trading Journey Today - earlytimes.in
ECOR Gains Coverage for gammaCore Sapphire in Belgium - GuruFocus
Electrocore announces reimbursement approval for gammaCore by Riziv/Inami in Belgium - MarketScreener
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium - GlobeNewswire
Major Reimbursement Win: electroCore's gammaCore Headache Device Gets National Coverage in Belgium - Stock Titan
What technical models suggest about electroCore Inc.’s comebackEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
electroCore Partners With Former Jets Linebacker for Truvaga Awareness - Medical Product Outsourcing
Maxim Group Maintains ElectroCore(ECOR.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence - 富途牛牛
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Goldberger Daniel S | Chief Executive Officer |
Aug 11 '25 |
Buy |
4.23 |
1,000 |
4,230 |
291,565 |
GANDOLFO JOHN P | Director |
May 23 '25 |
Buy |
5.01 |
1,800 |
9,018 |
69,087 |
Errico Thomas J. | Director |
May 12 '25 |
Buy |
4.77 |
10,000 |
47,735 |
266,401 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):